Barriers to and Motivations for Physician Referral of Patients to Cancer Genetics Clinics

被引:28
作者
Prochniak, Carrie F. [1 ]
Martin, Lisa J. [2 ,3 ]
Miller, Erin M. [4 ]
Knapke, Sara C.
机构
[1] Aurora Hlth Care, Dept Womens Hlth Oncol, Milwaukee, WI 53233 USA
[2] Univ Cincinnati, Sch Med, Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH USA
[3] Univ Cincinnati, Sch Med, Cincinnati Childrens Hosp Med Ctr, Div Human Genet,Dept Pediat, Cincinnati, OH USA
[4] Cincinnati Childrens Hosp Med Ctr, Inst Heart, Cincinnati, OH USA
关键词
Genetic counseling; Hereditary colorectal cancer; Genetic testing; Referral; Risk assessment; FAMILIAL COLORECTAL-CANCER; LYNCH-SYNDROME; PERCEPTIONS; ATTITUDES; AWARENESS; HISTORY;
D O I
10.1007/s10897-011-9401-x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Although it is well known that under-referral of colon cancer patients to cancer genetics clinics is a chronic problem, no study has yet examined why physicians may be ordering testing independently rather than referring patients to cancer genetics clinics. The current study explored variables which may impact a physician's preference for ordering testing independently or referring patients to outside cancer genetics experts. An online questionnaire, distributed to the membership of the American College of Gastroenterology and the American Society of Colorectal Surgeons, yielded responses from 298 physicians. Motivations to refer to cancer genetics clinics rather than order testing independently included fear of genetic discrimination and a belief that patients benefit from genetic counseling about the risks, benefits and consequences of testing. These results suggest that in order to increase referrals, genetic counselors must educate physicians about the unique benefits patients receive from participating in genetic counseling.
引用
收藏
页码:305 / 325
页数:21
相关论文
共 31 条
  • [2] [Anonymous], COL CANC FACTS FIG 2
  • [3] [Anonymous], 2019, NCCN CLIN PRACTICE G
  • [4] Batra S, 2002, AM J GASTROENTEROL, V97, P729
  • [5] Awareness and Utilization of BRCA1/2 Testing Among US Primary Care Physicians
    Bellcross, Cecelia A.
    Kolor, Katherine
    Goddard, Katrina A. B.
    Coates, Ralph J.
    Reyes, Michele
    Khoury, Muin J.
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2011, 40 (01) : 61 - 66
  • [6] Berg AO, 2009, GENET MED, V11, P35, DOI [10.1097/GIM.0b013e31818fa2ff, 10.1097/GIM.0b013e318181fa2ff]
  • [7] Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility:: Recommendation statement
    Berg, AO
    Allan, JD
    Calonge, N
    Frame, PS
    Gordis, L
    Gregory, KD
    Harris, R
    Johnson, MS
    Klein, JD
    Loveland-Cherry, C
    Moyer, VA
    Ockene, JK
    Petitti, DB
    Siu, AL
    Teutsch, SM
    Yawn, BP
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 143 (05) : 355 - 361
  • [8] Psychosocial issues in cancer genetics - Current status and future directions
    Bleiker, EMA
    Hahn, DEE
    Aaronson, NK
    [J]. ACTA ONCOLOGICA, 2003, 42 (04) : 276 - 286
  • [9] Cancer genetics evaluation: Barriers to and improvements for referral
    Brandt, Rachael
    Ali, Zonera
    Sabel, Allison
    McHugh, Terri
    Gilman, Paul
    [J]. GENETIC TESTING, 2008, 12 (01): : 9 - 12
  • [10] Brierley Karina L, 2010, Conn Med, V74, P413